Advertisement
Screener

NEUMORA THERAPEUTICS, INC. (NMRA) Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

NEUMORA THERAPEUTICS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

NEUMORA THERAPEUTICS, INC. (NMRA) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $239.79 million as of 2024-03-31, per its 10-Q filed 2024-05-07.

Discontinued › Notes

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2024-05-07

  • 2024-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $239.79M.
  • 2023-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $79.94M.
  • 2023-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $97.28M.
  • 2022-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $130.94M.
Period endDebt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
2024-03-31$239.79M
10-Q · filed 2024-05-07
2023-12-31$79.94M
10-K · filed 2024-03-07
2023-09-30$97.28M
10-Q · filed 2023-11-01
2022-12-31$130.94M
10-Q · filed 2023-11-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22